Overview

Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age

Status:
Completed
Trial end date:
2005-06-29
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this clinical trial is to evaluate the height gain during 12 months of growth hormone treatment in children born small for gestational age due to intrauterine growth retardation.
Phase:
Phase 3
Details
Lead Sponsor:
Novo Nordisk A/S